Palisade Bio
Price & Volume
Stats
See more52W Range | $0.53-$2.86 |
Market Cap | $371.1M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $500,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $500,000 |
Diluted EPS | $0.67 |
News
See moreYahoo Finance • 18 days ago
Palisade Bio Q2 Net Loss Expands; Plans Phase 2 ASCENTRA-UC Trial Enrollment In H2 2026; Stock Down
Yahoo Finance • 2 months ago
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
Yahoo Finance • 4 months ago
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
Yahoo Finance • 5 months ago
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
About
CEO | Mr. J. D. Finley |
CFO | Mr. J. D. Finley |
Address | 4600 South Syracuse Street, Denver, CO, United States, 80237 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |